يعرض 1 - 20 نتائج من 26 نتيجة بحث عن '"Annette Sauter"', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    Academic Journal
  4. 4

    المساهمون: Radiology and nuclear medicine, Amsterdam Neuroscience - Neuroinfection & -inflammation

    المصدر: Neurology, 93(19), e1778-e1786. Lippincott Williams and Wilkins
    Neurology
    Neurology, vol 93, iss 19
    Barkhof, F, Kappos, L, Wolinsky, J S, Li, D K B, Bar-Or, A, Hartung, H-P, Belachew, S, Han, J, Julian, L, Sauter, A, Napieralski, J, Koendgen, H & Hauser, S L 2019, ' Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis ', Neurology, vol. 93, no. 19, pp. e1778-e1786 . https://doi.org/10.1212/WNL.0000000000008189, https://doi.org/10.1212/WNL.0000000000008189

    وصف الملف: application/pdf

  5. 5
  6. 6
  7. 7

    المصدر: Multiple Sclerosis and Related Disorders

    مصطلحات موضوعية: Male, SPMS, Secondary progressive multiple sclerosis, RT-PCR, Real-time polymerase chain reaction, EHR, Electronic health record, Ig, Immunoglobulin, DMT, Disease-modifying therapy, 0302 clinical medicine, ocrelizumab, Risk Factors, Case fatality rate, Electronic Health Records, 030212 general & internal medicine, Aged, 80 and over, COVID-19, Coronavirus disease 2019, education.field_of_study, MS, Multiple sclerosis, PPMS, Primary progressive multiple sclerosis, General Medicine, Middle Aged, disease-modifying therapy, Hospitalization, CCOD, clinical cut-off date, Neurology, Cohort, Female, medicine.symptom, anti-CD20, AE, Adverse event, RMS, Relapsing multiple sclerosis, medicine.drug, Adult, medicine.medical_specialty, Multiple Sclerosis, Adolescent, Coronavirus disease 2019 (COVID-19), Population, macromolecular substances, BMI, Body mass index, Antibodies, Monoclonal, Humanized, Asymptomatic, Article, WHO, World Health Organization, EDSS, Expanded Disability Status Scale, Young Adult, 03 medical and health sciences, RWD, Real-world data, Internal medicine, medicine, Humans, education, Aged, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, CCI, Charlson Comorbidity Index, business.industry, Multiple sclerosis, COVID-19, medicine.disease, CI, confidence interval, Clinical trial, RRMS, Relapsing–remitting multiple sclerosis, CTCAE, Common Terminology Criteria for Adverse Events, Ocrelizumab, Neurology (clinical), business, 030217 neurology & neurosurgery

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20